<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02277821</url>
  </required_header>
  <id_info>
    <org_study_id>2014-A00804-43</org_study_id>
    <nct_id>NCT02277821</nct_id>
  </id_info>
  <brief_title>Evaluation of Stendo Pulsating Suit on Microcirculation and Central Blood Pressure in Essential Hypertension Patients</brief_title>
  <official_title>Evaluation of the Action of the Stendo Pulsating Suit on Peripheral Microcirculation and on Central Blood Pressure in Essential Hypertension Patients Treated But Not Stabilized</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stendo</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stendo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The action of one Stendo pulsating suit session will be evaluated on 24 patients referred to&#xD;
      the hypertension consultations for essential hypertension treated but not stabilized. The&#xD;
      effect of one Stendo pulsating suit session system will be mainly assessed on the peripheral&#xD;
      cutaneous microcirculation and on the central arterial pressure.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The role of the endothelium in micro-vascular system is mediated by synthesis and release of&#xD;
      numerous substances that act on the smooth muscle fibres. The release of these products is&#xD;
      modulated, in turn, by various circulating molecules, by the autonomic nervous system and by&#xD;
      local mechanical factors such as shear stress.&#xD;
&#xD;
      The essential hypertension is associated to increased risks of cardiovascular and stroke&#xD;
      morbidity and mortality and constitutes a major cause of severe kidney failure. The essential&#xD;
      hypertension is a complex and multi-factorial disease; the dysfunction of the endothelium is&#xD;
      of a great importance in the physiopathology of this disease, concerning both the&#xD;
      consequences of the increase of the blood pressure and the possible cause of the hypertension&#xD;
      development.&#xD;
&#xD;
      The Stendo pulsating suit is expected to increase the cutaneous microcirculation measured by&#xD;
      laser Doppler laser flowmetry and potentially to decrease the central blood pressure. Each&#xD;
      patient will be his own witness and the clinical records will be assessed before, during when&#xD;
      relevant, and after a pulsating suit session.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">July 2015</completion_date>
  <primary_completion_date type="Anticipated">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Peripheral microcirculation measured using Laser Doppler flowmetry</measure>
    <time_frame>35 minutes after the end of the Stendo session at D1 + 7 jours +/- 3</time_frame>
    <description>Change in % of the peripheral cutaneous microcirculation using laser Doppler flowmetry after one Stendo pulsating suit session</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Humeral arterial pressure</measure>
    <time_frame>20 minutes after the end of Stendo session at D1 + 7 jours +/- 3</time_frame>
    <description>Humeral arterial pressure using automatic measures with Dinamap device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Central blood pressure</measure>
    <time_frame>Just after the end of the Stendo session.at D1 + 7 jours +/- 3</time_frame>
    <description>Central blood pressure measured by applanation using an applanation tonometry device; Central pulse pressure, Augmentation Index and subendocardial viability ratio will also be assessed.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Essential Hypertension</condition>
  <arm_group>
    <arm_group_label>Stendo pulsating suit System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One 20 minutes Stendo pulsating suit session will be applied to the patient.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Stendo pulsating suit System</intervention_name>
    <description>The Stendo system, a multilayer pulsatile inflatable suit is applied to the lower limbs and the abdomen. This device induces a sequential compartmentalized compression synchronized with each diastolic phase of the cardiac cycle, each phase evolving centripetally (lower limbs to abdomen).</description>
    <arm_group_label>Stendo pulsating suit System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient referred to the Hypertension Hospital Consultation for essential hypertension&#xD;
             treated but not stabilized&#xD;
&#xD;
          -  Patient with essential hypertension defined by a brachial arterial pressure of 140 ≤&#xD;
             Systolic Arterial Pressure &lt; 180 mm Hg and/or 90 ≤ Diastolic Arterial - Pressure &lt; 110&#xD;
             mm Hg&#xD;
&#xD;
          -  Essential Hypertension confirmed by an ambulatory measure of the arterial pressure&#xD;
             during 24 hours before the pre-inclusion visit&#xD;
&#xD;
          -  Patients aged more than 40 and less than 70&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient with secondary hypertension&#xD;
&#xD;
          -  Patient with diabetes&#xD;
&#xD;
          -  Patient with complete arrhythmia with atrial fibrillation&#xD;
&#xD;
          -  Patient with an advanced obstructive arterial disease&#xD;
&#xD;
          -  Patient with a recent and progressive deep venous thrombosis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guy AMAH, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service de Physiologie Clinique - Explorations Fonctionnelles</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guy AMAH, MD</last_name>
    <phone>+331 49 95 80 88</phone>
    <email>guy.amah@lrb.aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital Lariboisière - Service de Physiologie Clinique - Explorations Fonctionnelles</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guy AMAH, MD</last_name>
      <phone>+33 1 49 95 80 88</phone>
      <email>guy.amah@lrb.aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <study_first_submitted>October 8, 2014</study_first_submitted>
  <study_first_submitted_qc>October 27, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 29, 2014</study_first_posted>
  <last_update_submitted>May 21, 2015</last_update_submitted>
  <last_update_submitted_qc>May 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Essential Hypertension</keyword>
  <keyword>Central Blood Pressure</keyword>
  <keyword>Microcirculation</keyword>
  <keyword>Endothelium Stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Essential Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

